Gabriel Leung's most recent trade in NovoCure Ltd was a trade of 16,697 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 4, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| NovoCure Ltd | Gabriel Leung | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 16,697 | 16,697 | - | - | Stock Option (Right to Buy) | |
| NovoCure Ltd | Gabriel Leung | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 11,215 | 92,444 (0%) | 0% | 0 | Ordinary Shares | |
| NovoCure Ltd | Gabriel Leung | Director | Sale of securities on an exchange or to another person at price $ 17.31 per share. | 03 Jun 2025 | 999 | 81,229 (0%) | 0% | 17.3 | 17,297 | Ordinary Shares |
| NovoCure Ltd | Gabriel Leung | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 6,229 | 6,229 | - | - | Stock Option (Right to Buy) | |
| NovoCure Ltd | Gabriel Leung | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 4,053 | 83,192 | - | 0 | Restricted Stock Units | |
| NovoCure Ltd | Gabriel Leung | Director | Sale of securities on an exchange or to another person at price $ 23.88 per share. | 04 Jun 2024 | 964 | 78,175 (0%) | 0% | 23.9 | 23,025 | Ordinary Shares |
| NovoCure Ltd | Gabriel Leung | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 6,277 | 6,277 | - | - | Stock Option (Right to Buy) | |
| NovoCure Ltd | Gabriel Leung | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 3,853 | 79,139 | - | 0 | Restricted Stock Units | |
| NovoCure Ltd | Gabriel Leung | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 4,350 | 4,350 | - | - | Options to Buy Ordinary Shares | |
| NovoCure Ltd | Gabriel Leung | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 2,427 | 75,286 | - | 0 | Restricted Stock Units | |
| NovoCure Ltd | Gabriel Leung | Director | Sale of securities on an exchange or to another person at price $ 152.50 per share. | 05 Aug 2021 | 1,000 | 72,859 (0%) | 0% | 152.5 | 152,500 | Ordinary Shares |
| NovoCure Ltd | Gabriel Leung | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Aug 2021 | 1,000 | 2,345 | - | - | Options to Buy Ordinary Shares | |
| NovoCure Ltd | Gabriel Leung | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 31.45 per share. | 05 Aug 2021 | 1,000 | 73,859 (0%) | 0% | 31.5 | 31,450 | Ordinary Shares |
| NovoCure Ltd | Gabriel Leung | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jul 2021 | 1,000 | 3,345 | - | - | Options to Buy Ordinary Shares | |
| NovoCure Ltd | Gabriel Leung | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 31.45 per share. | 06 Jul 2021 | 1,000 | 73,859 (0%) | 0% | 31.5 | 31,450 | Ordinary Shares |
| NovoCure Ltd | Gabriel Leung | Director | Sale of securities on an exchange or to another person at price $ 183.54 per share. | 06 Jul 2021 | 1,000 | 72,859 (0%) | 0% | 183.5 | 183,540 | Ordinary Shares |
| NovoCure Ltd | Gabriel Leung | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2021 | 1,499 | 1,499 | - | - | Options to Buy Ordinary Shares | |
| NovoCure Ltd | Gabriel Leung | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2021 | 814 | 72,859 | - | 0 | Restricted Stock Units | |
| NovoCure Ltd | Gabriel Leung | Director | Sale of securities on an exchange or to another person at price $ 204.55 per share. | 07 Jun 2021 | 1,000 | 72,045 (0%) | 0% | 204.6 | 204,550 | Ordinary Shares |
| NovoCure Ltd | Gabriel Leung | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2021 | 1,000 | 4,345 | - | - | Options to Buy Ordinary Shares | |
| NovoCure Ltd | Gabriel Leung | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 31.45 per share. | 07 Jun 2021 | 1,000 | 73,045 (0%) | 0% | 31.5 | 31,450 | Ordinary Shares |
| NovoCure Ltd | Gabriel Leung | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 31.45 per share. | 05 May 2021 | 1,000 | 73,045 (0%) | 0% | 31.5 | 31,450 | Ordinary Shares |
| NovoCure Ltd | Gabriel Leung | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 May 2021 | 1,000 | 5,345 | - | - | Options to Buy Ordinary Shares | |
| NovoCure Ltd | Gabriel Leung | Director | Sale of securities on an exchange or to another person at price $ 199.67 per share. | 05 May 2021 | 1,000 | 72,045 (0%) | 0% | 199.7 | 199,670 | Ordinary Shares |
| NovoCure Ltd | Gabriel Leung | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Apr 2021 | 6,000 | 6,345 | - | - | Options to Buy Ordinary Shares | |
| NovoCure Ltd | Gabriel Leung | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 31.45 per share. | 13 Apr 2021 | 6,000 | 78,045 (0%) | 0% | 31.5 | 188,700 | Ordinary Shares |
| NovoCure Ltd | Gabriel Leung | Director | Sale of securities on an exchange or to another person at price $ 198.01 per share. | 13 Apr 2021 | 3,500 | 74,545 (0%) | 0% | 198.0 | 693,035 | Ordinary Shares |
| NovoCure Ltd | Gabriel Leung | Director | Sale of securities on an exchange or to another person at price $ 200.00 per share. | 13 Apr 2021 | 2,500 | 72,045 (0%) | 0% | 200 | 500,000 | Ordinary Shares |
| NovoCure Ltd | Gabriel Leung | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Sep 2020 | 10,000 | 2,173 | - | - | Options to Buy Ordinary Shares | |
| NovoCure Ltd | Gabriel Leung | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.48 per share. | 14 Sep 2020 | 10,000 | 82,045 (0%) | 0% | 7.5 | 74,800 | Ordinary Shares |
| NovoCure Ltd | Gabriel Leung | Director | Sale of securities on an exchange or to another person at price $ 95.00 per share. | 14 Sep 2020 | 10,000 | 72,045 (0%) | 0% | 95 | 950,000 | Ordinary Shares |
| NovoCure Ltd | Gabriel Leung | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Sep 2020 | 7,392 | 0 | - | - | Options to Buy Ordinary Shares | |
| NovoCure Ltd | Gabriel Leung | Director | Sale of securities on an exchange or to another person at price $ 100.00 per share. | 14 Sep 2020 | 7,392 | 72,045 (0%) | 0% | 100 | 739,200 | Ordinary Shares |
| NovoCure Ltd | Gabriel Leung | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.48 per share. | 14 Sep 2020 | 7,392 | 79,437 (0%) | 0% | 7.5 | 55,292 | Ordinary Shares |
| NovoCure Ltd | Gabriel Leung | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Sep 2020 | 2,173 | 0 | - | - | Options to Buy Ordinary Shares | |
| NovoCure Ltd | Gabriel Leung | Director | Sale of securities on an exchange or to another person at price $ 100.00 per share. | 14 Sep 2020 | 2,173 | 72,045 (0%) | 0% | 100 | 217,300 | Ordinary Shares |
| NovoCure Ltd | Gabriel Leung | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.48 per share. | 14 Sep 2020 | 2,173 | 74,218 (0%) | 0% | 7.5 | 16,254 | Ordinary Shares |
| NovoCure Ltd | Gabriel Leung | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.48 per share. | 09 Sep 2020 | 10,000 | 82,045 (0%) | 0% | 7.5 | 74,800 | Ordinary Shares |
| NovoCure Ltd | Gabriel Leung | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2020 | 10,000 | 12,173 | - | - | Options to Buy Ordinary Shares | |
| NovoCure Ltd | Gabriel Leung | Director | Sale of securities on an exchange or to another person at price $ 90.00 per share. | 09 Sep 2020 | 10,000 | 72,045 (0%) | 0% | 90 | 900,000 | Ordinary Shares |
| NovoCure Ltd | Gabriel Leung | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.03 per share. | 09 Sep 2020 | 9,114 | 81,159 (0%) | 0% | 7.0 | 64,071 | Ordinary Shares |
| NovoCure Ltd | Gabriel Leung | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2020 | 9,114 | 0 | - | - | Options to Buy Ordinary Shares | |
| NovoCure Ltd | Gabriel Leung | Director | Sale of securities on an exchange or to another person at price $ 85.39 per share. | 09 Sep 2020 | 9,014 | 72,145 (0%) | 0% | 85.4 | 769,687 | Ordinary Shares |
| NovoCure Ltd | Gabriel Leung | Director | Sale of securities on an exchange or to another person at price $ 86.06 per share. | 09 Sep 2020 | 100 | 72,045 (0%) | 0% | 86.1 | 8,606 | Ordinary Shares |